(Q51737323)

11 April 2018

title

Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen. (English)

1 reference

11 April 2018

1 reference

2

D S Alberts

1 reference

11 April 2018

author name string

P M Plezia

1

1 reference

11 April 2018

J F Kessler

3

1 reference

11 April 2018

P L Berens

4

1 reference

11 April 2018

J L Chase

5

1 reference

11 April 2018

D J Roe

6

1 reference

11 April 2018

publication date

1 April 1990

1 reference

11 April 2018

Journal of Pain and Symptom Management

published in

1 reference

11 April 2018

volume

5

1 reference

11 April 2018

issue

2

1 reference

11 April 2018

page(s)

101-108

1 reference

11 April 2018

Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

High-dose dexamethasone for prevention of cis-platin-induced vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Antiemetics: neurotransmitter receptor binding predicts therapeutic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Chemotherapeutic agents do not interact with neurotransmitter receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Antiemetic effect of intravenous diazepam in patients receiving cis-diamminedichloroplatinum II: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2805%2980023-5

7 January 2021

10.1016/S0885-3924(05)80023-5

Identifiers

DOI

1 reference

11 April 2018

release_pryzgjp7zjbi3jo23tn7q3numm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pryzgjp7zjbi3jo23tn7q3numm

24 November 2022

mapped directly with Wikidata item

1 reference

11 April 2018